1 paper and 0 clinical trials exploring ayahuasca as a treatment for traumatic brain injury (tbi).
Ayahuasca is a botanical decoction combining DMT with MAO-inhibiting harmala alkaloids, producing intense psychedelic effects lasting 3-6 hours. Clinical trials show rapid, large antidepressant effects from a single dose, with a favourable safety profile in controlled settings.
Full Ayahuasca profilePsychedelics are being investigated for their potential therapeutic effects on Traumatic Brain Injury (TBI), a condition that frequently results in various physical and psychological impairments. Early preclinical studies suggest that these compounds may influence inflammatory responses, promote neuroplasticity, and enhance neurogenesis, offering new avenues for treatment.
Full Traumatic Brain Injury (TBI) profileNo clinical trials have been tagged with both Ayahuasca and Traumatic Brain Injury (TBI) yet.
Trials are continuously being added as new studies are registered.